Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
1(100.0%)
1Total
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07270419Recruiting

Aneurysmal Subarachnoid Hemorrhage Multi-Omics Research Program

Role: lead

NCT06061185Recruiting

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Role: lead

NCT06138353Phase 2Recruiting

Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)

Role: lead

All 3 trials loaded